EPO induces rise in serum ADMA but does not prevent the increase in NO release: the likely involvement of HO-1.
Calò
Lorenzo A
LA
Davis
Paul A
PA
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D004730:Endothelium, Vascular / Q000378:metabolism; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000494:pharmacology*; D051547:Heme Oxygenase-1 / Q000378:metabolism*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000628:therapy; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins; D006435:Renal Dialysis
D011994:Recombinant Proteins; D004921:Erythropoietin; D009569:Nitric Oxide; C018524:N,N-dimethylarginine; D000068817:Epoetin Alfa; D001120:Arginine; D019001:Nitric Oxide Synthase; C496541:HMOX1 protein, human; D051547:Heme Oxygenase-1